Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome

OBJECTIVE: We report an outbreak of Achromobacter xylosoxidans at a neonatal intensive care unit. We aimed to present clinical, laboratory and treatment data of the patients. Materials and METHODS: All consecutive episodes of bacteremia due to A. xylosoxidans at our neonatal intensive care unit, beginning with the index case detected at November 2009 until cessation of the outbreak in April 2010, were evaluated retrospectively. RESULTS: Thirty-four episodes of bacteremia occurred in 22 neonates during a 6-month period. Among the affected, 90% were preterm newborns with gestational age of 32 weeks or less and 60% had birth weight of 1000 g or less. Endotracheal intubation, intravenous catheter use, total parenteral nutrition and prolonged antibiotic therapy were the predisposing conditions. Presenting features were abdominal distention, thrombocytopenia and neutropenia. The mortality rate was 13.6% and the majority of isolates were susceptible to piperacillin-tazobactam, carbapenems and trimethoprim-sulfametoxazole, and resistant to gentamycin. More than half were breakthrough infections. Despite intensive efforts to control the outbreak by standard methods of hand hygiene, patient screening and isolation, containment could be achieved only after the neonatal intensive care unit was relocated. The investigation was not able to single out the source of the outbreak. CONCLUSION: A. xylosoxidans has the potential to cause serious infections in premature babies. More studies are needed to determine the importance of different sources of infection in hospital units.

Saved in:
Bibliographic Details
Main Authors: Turel,Ozden, Kavuncuoglu,Sultan, Hosaf,Emine, Ozbek,Sibel, Aldemir,Esin, Uygur,Turkan, Hatipoglu,Nevin, Siraneci,Rengin
Format: Digital revista
Language:English
Published: Brazilian Society of Infectious Diseases 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000400011
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1413-86702013000400011
record_format ojs
spelling oai:scielo:S1413-867020130004000112013-08-16Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcomeTurel,OzdenKavuncuoglu,SultanHosaf,EmineOzbek,SibelAldemir,EsinUygur,TurkanHatipoglu,NevinSiraneci,Rengin Achromobacter xylosoxidans Bloodstream infection Neonate OBJECTIVE: We report an outbreak of Achromobacter xylosoxidans at a neonatal intensive care unit. We aimed to present clinical, laboratory and treatment data of the patients. Materials and METHODS: All consecutive episodes of bacteremia due to A. xylosoxidans at our neonatal intensive care unit, beginning with the index case detected at November 2009 until cessation of the outbreak in April 2010, were evaluated retrospectively. RESULTS: Thirty-four episodes of bacteremia occurred in 22 neonates during a 6-month period. Among the affected, 90% were preterm newborns with gestational age of 32 weeks or less and 60% had birth weight of 1000 g or less. Endotracheal intubation, intravenous catheter use, total parenteral nutrition and prolonged antibiotic therapy were the predisposing conditions. Presenting features were abdominal distention, thrombocytopenia and neutropenia. The mortality rate was 13.6% and the majority of isolates were susceptible to piperacillin-tazobactam, carbapenems and trimethoprim-sulfametoxazole, and resistant to gentamycin. More than half were breakthrough infections. Despite intensive efforts to control the outbreak by standard methods of hand hygiene, patient screening and isolation, containment could be achieved only after the neonatal intensive care unit was relocated. The investigation was not able to single out the source of the outbreak. CONCLUSION: A. xylosoxidans has the potential to cause serious infections in premature babies. More studies are needed to determine the importance of different sources of infection in hospital units.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.17 n.4 20132013-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000400011en10.1016/j.bjid.2013.01.008
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Turel,Ozden
Kavuncuoglu,Sultan
Hosaf,Emine
Ozbek,Sibel
Aldemir,Esin
Uygur,Turkan
Hatipoglu,Nevin
Siraneci,Rengin
spellingShingle Turel,Ozden
Kavuncuoglu,Sultan
Hosaf,Emine
Ozbek,Sibel
Aldemir,Esin
Uygur,Turkan
Hatipoglu,Nevin
Siraneci,Rengin
Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
author_facet Turel,Ozden
Kavuncuoglu,Sultan
Hosaf,Emine
Ozbek,Sibel
Aldemir,Esin
Uygur,Turkan
Hatipoglu,Nevin
Siraneci,Rengin
author_sort Turel,Ozden
title Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_short Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_full Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_fullStr Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_full_unstemmed Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_sort bacteremia due to achromobacter xylosoxidans in neonates: clinical features and outcome
description OBJECTIVE: We report an outbreak of Achromobacter xylosoxidans at a neonatal intensive care unit. We aimed to present clinical, laboratory and treatment data of the patients. Materials and METHODS: All consecutive episodes of bacteremia due to A. xylosoxidans at our neonatal intensive care unit, beginning with the index case detected at November 2009 until cessation of the outbreak in April 2010, were evaluated retrospectively. RESULTS: Thirty-four episodes of bacteremia occurred in 22 neonates during a 6-month period. Among the affected, 90% were preterm newborns with gestational age of 32 weeks or less and 60% had birth weight of 1000 g or less. Endotracheal intubation, intravenous catheter use, total parenteral nutrition and prolonged antibiotic therapy were the predisposing conditions. Presenting features were abdominal distention, thrombocytopenia and neutropenia. The mortality rate was 13.6% and the majority of isolates were susceptible to piperacillin-tazobactam, carbapenems and trimethoprim-sulfametoxazole, and resistant to gentamycin. More than half were breakthrough infections. Despite intensive efforts to control the outbreak by standard methods of hand hygiene, patient screening and isolation, containment could be achieved only after the neonatal intensive care unit was relocated. The investigation was not able to single out the source of the outbreak. CONCLUSION: A. xylosoxidans has the potential to cause serious infections in premature babies. More studies are needed to determine the importance of different sources of infection in hospital units.
publisher Brazilian Society of Infectious Diseases
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000400011
work_keys_str_mv AT turelozden bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT kavuncuoglusultan bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT hosafemine bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT ozbeksibel bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT aldemiresin bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT uygurturkan bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT hatipoglunevin bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT siranecirengin bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
_version_ 1756416470761340928